Cargando…
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
In this multi-institutional study we compiled a retrospective cohort of 86 posterior fossa tumors having received the diagnosis of cerebellar glioblastoma (cGBM). All tumors were reviewed histologically and subjected to array-based methylation analysis followed by algorithm-based classification into...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816155/ https://www.ncbi.nlm.nih.gov/pubmed/31661039 http://dx.doi.org/10.1186/s40478-019-0801-8 |
_version_ | 1783463326507859968 |
---|---|
author | Reinhardt, Annekathrin Stichel, Damian Schrimpf, Daniel Koelsche, Christian Wefers, Annika K. Ebrahimi, Azadeh Sievers, Philipp Huang, Kristin Casalini, M. Belén Fernández-Klett, Francisco Suwala, Abigail Weller, Michael Gramatzki, Dorothee Felsberg, Joerg Reifenberger, Guido Becker, Albert Hans, Volkmar H. Prinz, Marco Staszewski, Ori Acker, Till Dohmen, Hildegard Hartmann, Christian Paulus, Werner Heß, Katharina Brokinkel, Benjamin Schittenhelm, Jens Buslei, Rolf Deckert, Martina Mawrin, Christian Hewer, Ekkehard Pohl, Ute Jaunmuktane, Zane Brandner, Sebastian Unterberg, Andreas Hänggi, Daniel Platten, Michael Pfister, Stefan M. Wick, Wolfgang Herold-Mende, Christel Korshunov, Andrey Reuss, David E. Sahm, Felix Jones, David T. W. Capper, David von Deimling, Andreas |
author_facet | Reinhardt, Annekathrin Stichel, Damian Schrimpf, Daniel Koelsche, Christian Wefers, Annika K. Ebrahimi, Azadeh Sievers, Philipp Huang, Kristin Casalini, M. Belén Fernández-Klett, Francisco Suwala, Abigail Weller, Michael Gramatzki, Dorothee Felsberg, Joerg Reifenberger, Guido Becker, Albert Hans, Volkmar H. Prinz, Marco Staszewski, Ori Acker, Till Dohmen, Hildegard Hartmann, Christian Paulus, Werner Heß, Katharina Brokinkel, Benjamin Schittenhelm, Jens Buslei, Rolf Deckert, Martina Mawrin, Christian Hewer, Ekkehard Pohl, Ute Jaunmuktane, Zane Brandner, Sebastian Unterberg, Andreas Hänggi, Daniel Platten, Michael Pfister, Stefan M. Wick, Wolfgang Herold-Mende, Christel Korshunov, Andrey Reuss, David E. Sahm, Felix Jones, David T. W. Capper, David von Deimling, Andreas |
author_sort | Reinhardt, Annekathrin |
collection | PubMed |
description | In this multi-institutional study we compiled a retrospective cohort of 86 posterior fossa tumors having received the diagnosis of cerebellar glioblastoma (cGBM). All tumors were reviewed histologically and subjected to array-based methylation analysis followed by algorithm-based classification into distinct methylation classes (MCs). The single MC containing the largest proportion of 25 tumors diagnosed as cGBM was MC anaplastic astrocytoma with piloid features representing a recently-described molecular tumor entity not yet included in the WHO Classification of Tumours of the Central Nervous System (WHO classification). Twenty-nine tumors molecularly corresponded to either of 6 methylation subclasses subsumed in the MC family GBM IDH wildtype. Further we identified 6 tumors belonging to the MC diffuse midline glioma H3 K27 M mutant and 6 tumors allotted to the MC IDH mutant glioma subclass astrocytoma. Two tumors were classified as MC pilocytic astrocytoma of the posterior fossa, one as MC CNS high grade neuroepithelial tumor with BCOR alteration and one as MC control tissue, inflammatory tumor microenvironment. The methylation profiles of 16 tumors could not clearly be assigned to one distinct MC. In comparison to supratentorial localization, the MC GBM IDH wildtype subclass midline was overrepresented, whereas the MCs GBM IDH wildtype subclass mesenchymal and subclass RTK II were underrepresented in the cerebellum. Based on the integration of molecular and histological findings all tumors received an integrated diagnosis in line with the WHO classification 2016. In conclusion, cGBM does not represent a molecularly uniform tumor entity, but rather comprises different brain tumor entities with diverse prognosis and therapeutic options. Distinction of these molecular tumor classes requires molecular analysis. More than 30% of tumors diagnosed as cGBM belong to the recently described molecular entity of anaplastic astrocytoma with piloid features. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0801-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6816155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68161552019-10-31 Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities Reinhardt, Annekathrin Stichel, Damian Schrimpf, Daniel Koelsche, Christian Wefers, Annika K. Ebrahimi, Azadeh Sievers, Philipp Huang, Kristin Casalini, M. Belén Fernández-Klett, Francisco Suwala, Abigail Weller, Michael Gramatzki, Dorothee Felsberg, Joerg Reifenberger, Guido Becker, Albert Hans, Volkmar H. Prinz, Marco Staszewski, Ori Acker, Till Dohmen, Hildegard Hartmann, Christian Paulus, Werner Heß, Katharina Brokinkel, Benjamin Schittenhelm, Jens Buslei, Rolf Deckert, Martina Mawrin, Christian Hewer, Ekkehard Pohl, Ute Jaunmuktane, Zane Brandner, Sebastian Unterberg, Andreas Hänggi, Daniel Platten, Michael Pfister, Stefan M. Wick, Wolfgang Herold-Mende, Christel Korshunov, Andrey Reuss, David E. Sahm, Felix Jones, David T. W. Capper, David von Deimling, Andreas Acta Neuropathol Commun Research In this multi-institutional study we compiled a retrospective cohort of 86 posterior fossa tumors having received the diagnosis of cerebellar glioblastoma (cGBM). All tumors were reviewed histologically and subjected to array-based methylation analysis followed by algorithm-based classification into distinct methylation classes (MCs). The single MC containing the largest proportion of 25 tumors diagnosed as cGBM was MC anaplastic astrocytoma with piloid features representing a recently-described molecular tumor entity not yet included in the WHO Classification of Tumours of the Central Nervous System (WHO classification). Twenty-nine tumors molecularly corresponded to either of 6 methylation subclasses subsumed in the MC family GBM IDH wildtype. Further we identified 6 tumors belonging to the MC diffuse midline glioma H3 K27 M mutant and 6 tumors allotted to the MC IDH mutant glioma subclass astrocytoma. Two tumors were classified as MC pilocytic astrocytoma of the posterior fossa, one as MC CNS high grade neuroepithelial tumor with BCOR alteration and one as MC control tissue, inflammatory tumor microenvironment. The methylation profiles of 16 tumors could not clearly be assigned to one distinct MC. In comparison to supratentorial localization, the MC GBM IDH wildtype subclass midline was overrepresented, whereas the MCs GBM IDH wildtype subclass mesenchymal and subclass RTK II were underrepresented in the cerebellum. Based on the integration of molecular and histological findings all tumors received an integrated diagnosis in line with the WHO classification 2016. In conclusion, cGBM does not represent a molecularly uniform tumor entity, but rather comprises different brain tumor entities with diverse prognosis and therapeutic options. Distinction of these molecular tumor classes requires molecular analysis. More than 30% of tumors diagnosed as cGBM belong to the recently described molecular entity of anaplastic astrocytoma with piloid features. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0801-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-10-28 /pmc/articles/PMC6816155/ /pubmed/31661039 http://dx.doi.org/10.1186/s40478-019-0801-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Reinhardt, Annekathrin Stichel, Damian Schrimpf, Daniel Koelsche, Christian Wefers, Annika K. Ebrahimi, Azadeh Sievers, Philipp Huang, Kristin Casalini, M. Belén Fernández-Klett, Francisco Suwala, Abigail Weller, Michael Gramatzki, Dorothee Felsberg, Joerg Reifenberger, Guido Becker, Albert Hans, Volkmar H. Prinz, Marco Staszewski, Ori Acker, Till Dohmen, Hildegard Hartmann, Christian Paulus, Werner Heß, Katharina Brokinkel, Benjamin Schittenhelm, Jens Buslei, Rolf Deckert, Martina Mawrin, Christian Hewer, Ekkehard Pohl, Ute Jaunmuktane, Zane Brandner, Sebastian Unterberg, Andreas Hänggi, Daniel Platten, Michael Pfister, Stefan M. Wick, Wolfgang Herold-Mende, Christel Korshunov, Andrey Reuss, David E. Sahm, Felix Jones, David T. W. Capper, David von Deimling, Andreas Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities |
title | Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities |
title_full | Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities |
title_fullStr | Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities |
title_full_unstemmed | Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities |
title_short | Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities |
title_sort | tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816155/ https://www.ncbi.nlm.nih.gov/pubmed/31661039 http://dx.doi.org/10.1186/s40478-019-0801-8 |
work_keys_str_mv | AT reinhardtannekathrin tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT sticheldamian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT schrimpfdaniel tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT koelschechristian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT wefersannikak tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT ebrahimiazadeh tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT sieversphilipp tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT huangkristin tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT casalinimbelen tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT fernandezklettfrancisco tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT suwalaabigail tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT wellermichael tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT gramatzkidorothee tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT felsbergjoerg tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT reifenbergerguido tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT beckeralbert tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT hansvolkmarh tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT prinzmarco tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT staszewskiori tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT ackertill tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT dohmenhildegard tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT hartmannchristian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT pauluswerner tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT heßkatharina tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT brokinkelbenjamin tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT schittenhelmjens tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT busleirolf tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT deckertmartina tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT mawrinchristian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT hewerekkehard tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT pohlute tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT jaunmuktanezane tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT brandnersebastian tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT unterbergandreas tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT hanggidaniel tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT plattenmichael tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT pfisterstefanm tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT wickwolfgang tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT heroldmendechristel tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT korshunovandrey tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT reussdavide tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT sahmfelix tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT jonesdavidtw tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT capperdavid tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities AT vondeimlingandreas tumorsdiagnosedascerebellarglioblastomacomprisedistinctmolecularentities |